BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
금요일, 9월 25

Artelo Biosciences Inc

ARTLNASDAQ
Trade with Public
Trade with Public
$5.17
-2.14-29.27%
가까이에: Sep 24, 5:00 PM EST
$4.91
-0.26-5.03%
시간외: 7:54 PM EST
PRO
변동 이유?:Artelo Biosciences shares are trading higher after the company announced th...
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교주식 보고서

Artelo Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Artelo Biosciences (ARTL).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

2Buy
2Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$891Upside to Avg. PT+18046.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Nov 19, 2025Maxim GroupJason McCarthyDowngradeBuy→Hold—
Sep 8, 2025D. Boral CapitalJason KolbertDowngradeBuy→Hold—
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Downgrades Artelo Biosciences to Hold

Maxim Group analyst Jason McCarthy downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.
Benzinga Newsdesk

This Science Applications International Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Avi Kapoor

PRO
D. Boral Capital Downgrades Artelo Biosciences to Hold

D. Boral Capital analyst Jason Kolbert downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved